MedicineEngineering

Yanyi Wang, Jiangyan Ren, Ting-yu Ren, Baochao Li, Jianchuan Ran, Huijuan Wang, Ziwei Huang, Diya Xie, Tao Liu, Linzhong Yang, Jinglun Zhang, Caixia Zhang, Zhi Wang, Xingyu Luo, Lei Zheng, Xiaoji Xie, Huang Li, Wei Han

2026.3.8JOURNAL OF NANOBIOTECHNOLOGY

DOI: 10.1186/s12951-026-04258-9

tlooto Summary

This study reveals thermal immunomodulation of synovial macrophages as a potential mechanism for TMJOA remission and establishes a targeted nanoplatform for spatial control of joint inflammation.

Abstract

Temporomandibular joint osteoarthritis (TMJOA) involves progressive synovial inflammation-driven cartilage degeneration. While thermotherapy empirically alleviates symptoms, its immunomodulatory mechanism remains elucidated. Here, we revealed that targeted mild hyperthermia reprogramed synovial M1 macrophages via NF-κB pathway suppression, shifting their secretome to attenuate chondrocyte catabolism while enhancing anabolism. This thermally-modified macrophage conditioned medium concurrently promoted osteogenic mineralization. Capitalizing on this, we engineered folic acid-conjugated Y8 nanocomposites (FA-Y8 NPs) for precision M1-targeting photothermal therapy. Under 808 nm irradiation, FA-Y8 NPs achieved localized photothermal reprogramming of synovial M1 macrophages and attenuating cartilage degradation in CFA-induced TMJOA mice. This study reveals thermal immunomodulation of synovial macrophages as a potential mechanism for TMJOA remission and establishes a targeted nanoplatform for spatial control of joint inflammation.

Citation format

WANG, Yanyi, et al. Photothermal reprogramming of synovial m1 macrophages reshapes the pro-inflammatory microenvironment to reverse temporomandibular joint osteoarthritis. JOURNAL OF NANOBIOTECHNOLOGY, 2026, 24(1): 361.